The health threat of drugs of abuse adulteration by new psychoactive substances

被引：4
|
作者：
Minutillo, A. [1 ]
Palmi, I. [1 ]
Mastrobattista, L. [1 ]
机构：
[1] Ist Super Sanita, Ctr Nazl Dipendenze & Doping, Viale Regina Elena 299, I-00161 Rome, Italy
来源：
CLINICA TERAPEUTICA | 2019年 / 170卷 / 06期
关键词：
new psychoactive substances; adulteration; drug of abuse; HEROIN; GHB;
D O I：
10.7417/CT.2019.2170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The practice of drug of abuse adulteration is changing. Currently, the risk of new adulteration practices involves New Psychoactive Substances (NPS), which can also be used as adulterants. In particular, the phenomenon of adulteration concerns fentanyl and its analogs, substances that can be toxic even if taken in very small quantities. The adulteration that involves NPS is creating a serious threat to the health of drug users, not only because of the pharmacological action but because of the increased toxicity of these new cutting agents.
引用
收藏
页码：E425 / E426
页数：2
相关论文
共 50 条
  • [1] Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
    Di Trana, Annagiulia
    Berardinelli, Diletta
    Montanari, Eva
    Berretta, Paolo
    Basile, Giuseppe
    Huestis, Marilyn A.
    Busardo, Francesco Paolo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [2] The dilemma of new psychoactive substances: A growing threat
    Sajwani, Hawraa Sameer
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (03) : 348 - 350
  • [3] New Psychoactive Substances - Designer Drugs
    Golec, Tina Caks
    Krzan, Mojca
    Zupanc, Tomaz
    REVIJA ZA KRIMINALISTIKO IN KRIMINOLOGIJO, 2018, 69 (03): : 206 - 214
  • [4] Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater
    Bade, Richard
    van Herwerden, Denice
    Rousis, Nikolaos
    Adhikari, Sangeet
    Allen, Darren
    Baduel, Christine
    Bijlsma, Lubertus
    Boogaerts, Tim
    Burgard, Dan
    Chappell, Andrew
    Driver, Erin M.
    Sodre, Fernando Fabriz
    Fatta-Kassinos, Despo
    Gracia-Lor, Emma
    Gracia-Marin, Elisa
    Halden, Rolf U.
    Heath, Ester
    Jaunay, Emma
    Krotulski, Alex
    Lai, Foon Yin
    Love, Arndis Sue Ching
    O'Brien, Jake W.
    Oh, Jeong-Eun
    Pasin, Daniel
    Castro, Marco Pineda
    Psichoudaki, Magda
    Salgueiro-Gonzalez, Noelia
    Gomes, Cezar Silvino
    Subedi, Bikram
    V. Thomas, Kevin
    Thomaidis, Nikolaos
    Wang, Degao
    Yargeau, Viviane
    Samanipour, Saer
    Mueller, Jochen
    JOURNAL OF HAZARDOUS MATERIALS, 2024, 469
  • [5] Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples
    Axelsson, Magnus A. B.
    Lovgren, Hanna
    Kronstrand, Robert
    Green, Henrik
    Bergstrom, Moa Andresen
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2025, 136 (02)
  • [6] Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review
    Solimini, Renata
    Rotolo, Maria C.
    Pellegrini, Manuela
    Minutillo, Adele
    Pacifici, Roberta
    Busardo, Francesco P.
    Zaami, Simona
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (07) : 524 - 530
  • [7] New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard
    Zaami, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 9681 - 9690
  • [8] The health threat of new synthetic opioids as adulterants of classic drugs of abuse
    Rinaldi, R.
    Negro, F.
    Minutillo, A.
    CLINICA TERAPEUTICA, 2020, 171 (02): : E107 - E109
  • [9] New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
    Vidal Gine, Claudio
    Fornis Espinosa, Ivan
    Ventura Vilamala, Mireia
    DRUG TESTING AND ANALYSIS, 2014, 6 (7-8) : 819 - 824
  • [10] Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse
    Beck, Olof
    Rausberg, Linnea
    Al-Saffar, Yasir
    Villen, Tomas
    Karlsson, Lennart
    Hansson, Therese
    Helander, Anders
    DRUG TESTING AND ANALYSIS, 2014, 6 (05) : 492 - 499
12345